ANALYSIS OF A LARGE COLLECTION OF NATURAL HIV-1 INTEGRASE SEQUENCES, INCLUDING THOSE FROM LONG-TERM NONPROGRESSORS

Citation
Lm. Skinner et al., ANALYSIS OF A LARGE COLLECTION OF NATURAL HIV-1 INTEGRASE SEQUENCES, INCLUDING THOSE FROM LONG-TERM NONPROGRESSORS, Journal of acquired immune deficiency syndromes and human retrovirology, 19(2), 1998, pp. 99-110
Citations number
60
Categorie Soggetti
Immunology,"Infectious Diseases
ISSN journal
10779450
Volume
19
Issue
2
Year of publication
1998
Pages
99 - 110
Database
ISI
SICI code
1077-9450(1998)19:2<99:AOALCO>2.0.ZU;2-K
Abstract
A large collection of natural HIV-1 integrase (IN) sequences has not p reviously been described. We reasoned that analysis of such sequences would address whether natural variation of HIV-1 IN contributes to the pathogenesis of AIDS and might also identify amino acid residues impo rtant for IN function. Sequences encoding HIV-I IN were amplified from cryopreserved lymphocytes or plasma obtained at different times from 10 hemophilia patients who had been observed for up to 17 years. The r egion of the HIV-1 genome that encodes the 288-amino acid IN protein w as sequenced from a total of 102 clones; information was obtained for 99.97% of 29,478 amino acid positions. Phylogenetic analysis indicated that patient samples were unique. Interpatient nucleic acid distances ranged from 0.8% to 4.9%, highlighting the tight conservation of this genomic region. No major differences were found between DNA and RNA o r between early and late time points from the same patient. Significan tly, no amino acid changes that might account for the variable rate of disease progression between patients were evident. Only one amino aci d substitution involved a highly conserved residue known to be importa nt for enzymatic activity. However, several interesting amino acid sub stitutions were noted, including residues within the C-terminal region of the protein for which sequence comparisons between animal retrovir uses have not been very informative. These results should encourage th e pursuit of anti-integrase therapies, especially inasmuch as the appa rent biologic constraints on the IN sequence may deter the development of drug resistance.